Provided by Tiger Trade Technology Pte. Ltd.

Boston Scientific

69.78
+1.632.39%
Post-market: 69.780.00000.00%17:47 EDT
Volume:9.44M
Turnover:655.90M
Market Cap:103.44B
PE:35.97
High:70.10
Open:69.00
Low:68.60
Close:68.15
52wk High:109.50
52wk Low:67.56
Shares:1.48B
Float Shares:1.48B
Volume Ratio:0.73
T/O Rate:0.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.94
EPS(LYR):1.94
ROE:12.45%
ROA:5.98%
PB:4.27
PE(LYR):35.97

Loading ...

Medical equipment maker Penumbra beats Q4 revenue expectations

Reuters
·
Feb 26

Penumbra Q4 revenue rises 22.1% to USD 385.4 million

Reuters
·
Feb 26

Penumbra Inc - Will Not Provide 2026 Guidance Due to Acquisition by Boston Scientific

THOMSON REUTERS
·
Feb 26

Press Release: Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

Dow Jones
·
Feb 26

RPT-BREAKINGVIEWS-Cash-and-stock mixers sweeten M&A spirits

Reuters
·
Feb 25

Boston Scientific Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 25

Boston Scientific Files Initial Beneficial Ownership Statement for Director Christophe Pierre Weber

Reuters
·
Feb 25

Boston Scientific Expands Share Buyback by $4 Billion, Adds Two Directors

MT Newswires Live
·
Feb 24

Boston Scientific Expands Board and Boosts Share Buybacks

TIPRANKS
·
Feb 24

Boston Scientific Corp - Increases Stock Repurchase Authorization to $5 Bln - SEC Filing

THOMSON REUTERS
·
Feb 24

Boston Scientific names Cathy Smith, Christophe Weber to board of directors

TIPRANKS
·
Feb 23

Boston Scientific Elects Cathy Smith and Christophe Weber to Board

Reuters
·
Feb 23

Boston Scientific Corp. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Feb 21

BTIG Reaffirms Their Buy Rating on Boston Scientific (BSX)

TIPRANKS
·
Feb 21

Boston Scientific’s TheraSphere Trial in Japan Signals New Growth Path in Liver Cancer

TIPRANKS
·
Feb 21

Goldman Sachs Adjusts Boston Scientific Price Target to $98 From $99, Maintains Buy Rating

MT Newswires Live
·
Feb 19

Back on the Radar: Prior Picks Offer Fresh Opportunity -- Barrons.com

Dow Jones
·
Feb 18

Boston Scientific: BUY on WATCHMAN Growth Optionality and Favorable CHAMPION-AF Risk/Reward Setup

TIPRANKS
·
Feb 18

Boston Scientific Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 18

Boston Scientific’s OPTION-EMEA Trial Targets One-Stop AF and Stroke Protection

TIPRANKS
·
Feb 18